Blood Group Substances as Potential Therapeutic Agents for the Prevention and Treatment of Infection with Noroviruses Proving Novel Binding Patterns in Human Tissues-Reference-Cited by-同舟云学术

Blood Group Substances as Potential Therapeutic Agents for the Prevention and Treatment of Infection with Noroviruses Proving Novel Binding Patterns in Human Tissues

Published:2014-02-18 Issue:2 Volume:9 Page:e89071
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yazawa Shin,Yokobori Takehiko,Ueta Gen,Ide Munenori,Altan Bolag,Thongprachum Aksara,Nishimura Toyo,Nakajima Tamiko,Kominato Yoshihiko,Asao Takayuki,Saniabadi Abby R.,Furukawa Kiyoshi,Kuwano Hiroyuki,Le Pendu Jacques,Ushijima Hiroshi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference80 articles.

1. Biological properties of Norwalk agent of acute infectious nonbacterial gastroenteritis;R Dolin;Proc Soc Exp Biol Med,1972

2. Identification of a distinct common strain of “Norwalk-like viruses” having a global distribution;JS Noel;J Infect Dis,1999

3. Surveillance of viral gastroenteritis in Japan: pediatric cases and outbreak incidents;S Inouye;J Infect Dis,2000

4. Increase in viral gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant;B Lopman;Lancet,2004

5. Norovirus disease: changing epidemiology and host susceptibility factors;AM Hutson;Trends in Microbiol,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Prognostic Analysis of Tumor-Related Blood Group Antigens in Pan-Cancers Suggests That SEMA7A as a Novel Biomarker in Kidney Renal Clear Cell Carcinoma;International Journal of Molecular Sciences;2022-08-08

2. Structural Insight into Terminal Galactose Recognition by Two Non-HBGA Binding GI.3 Noroviruses;Journal of Virology;2022-07-13

3. ABO ( H ) and Lewis blood group substances and disease treatment;Transfusion Medicine;2021-09-26

4. Virus like particles of GII.4 norovirus bind Toll Like Receptors 2 and 5;Immunology Letters;2019-11

5. Antinorovirus Drugs: Current and Future Perspectives;Norovirus;2019